Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy – single institute experience. Radiol Oncol. 2021;55(4):482-490. Accessed September 20, 2026. https://radioloncol.com/index.php/ro/article/view/3757